PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
September 1, 2021Women s Health Reports5 citationsOpen Access

Narrative Analyses: Cognitive Behavior Group Therapy for Women with Menopause and Bipolar or Major Depressive Disorders

View Full Paper
DCDanette ConklinJCJanet S. CarpenterMWMeredith Sorenson Whitney

Key Points

Key points are not available for this paper at this time.

Abstract

Background: Bipolar and depressive disorders (bipolar disorder BD, major depressive disorder MDD), as well as menopause affect millions of women. Although there are three known cognitive behavioral group treatment (CBGT) protocols to help women with problematic menopause symptoms, they do not target women on the BD or MDD spectrum. The purpose of this qualitative study was to learn more about the treatment needs and group experiences of women with problematic menopause symptoms and diagnosed on the BD and MDD spectrum, who participated in a CBGT intervention for menopausal symptoms. Methods: Narrative data recorded by clinicians (Interventionists' notes) and participants (Evaluation of Groups Survey) were analyzed using content analyses. Results: Several themes emerged from (n = 11 BD; n = 48 MDD) what women wanted help with (specific symptoms and general aspects of menopause), what women liked about CBGT (specific and general aspects of the program), and changes needed in the CBGT intervention (things wished for and barriers that interfered with the program). The two diagnostic groups differed in their responses, although both groups identified content and delivery gaps they wished would be addressed. Specifically related to their diagnosis, women most commonly talked about problems with worsening mood and mood instability and multiple stressors interfering with their ability to follow through with the intervention. Conclusions: These findings can help refine existing CBGT protocols for women diagnosed on the BD and MDD spectrum seeking help for menopause symptoms. Trial Registry: Parent study ClinicalTrials.gov identifier: NCT02860910.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Conklin et al. (2021) studied this question.

synapsesocial.com/papers/6a1d16d573c56dd1bd2f2535https://doi.org/10.1089/whr.2021.0025
Ask AI
Helpful
Bookmark
Share
View Full Paper